Insider transaction details
Gary A. Coombe, who serves as CEO - Grooming at Procter & Gamble Co (NYSE: PG), sold 36,093 shares of common stock on February 12, 2026. The disposition generated $5.86 million in proceeds, with the shares disposed at a weighted average price in the narrow band of $162.33 to $162.35.
On that same day, Coombe exercised stock options to acquire 36,093 shares of Procter & Gamble common stock at an exercise price of $78.52 per share, representing a total cost of $2.83 million for the option exercise.
Post-transaction ownership
Following the option exercises and the share sale, Coombe's direct ownership in Procter & Gamble stands at 34,993.7893 shares. In addition to his direct holdings, he has indirect stakes consisting of 486.4342 shares held by a Retirement Plan Trustee and 1,295.35 shares held through the International Stock Ownership Plan & Pension Plan (Switzerland).
Company results and analyst responses
Separately, Procter & Gamble disclosed fiscal second-quarter 2026 financial results in which reported earnings per share were $1.88, modestly above the consensus estimate of $1.86. Revenue for the quarter was $22.2 billion, slightly under the expected $22.34 billion.
Following the earnings release, a number of investment banks adjusted their price targets and ratings. UBS raised its price target to $170 and maintained a Buy rating. Wells Fargo set a new target of $165 while keeping an Overweight rating. BofA Securities nudged its price target to $171 and continued to rate the stock as Buy. JPMorgan moved Procter & Gamble from Neutral to Overweight, citing an optimistic outlook for growth and the potential for margin improvement.
Context and tone
These developments - the insider option exercise and sale, combined with mixed quarterly results and subsequent analyst adjustments - were characterized by the reporting as producing cautious optimism among analysts about Procter & Gamble's future performance. The documented insider activity, the precise ownership figures, the quarter's financial metrics, and the named analyst actions are reported facts without additional interpretation beyond the figures and decisions disclosed.